CLEAN - Clean Science and Technology Limited Share Price

Chemicals & Petrochemicals

₹1176.40-19.60(-1.64%)

Market Closed as of Aug 8, 2025, 15:30 IST

Select time range

Valuation
Market Cap	12.83 kCr
Price/Earnings (Trailing)	47.77
Price/Sales (Trailing)	12.48
EV/EBITDA	29.45
Price/Free Cashflow	178.45
MarketCap/EBT	35.38
Enterprise Value	12.81 kCr

Fundamentals
Revenue (TTM)	1.03 kCr
Rev. Growth (Yr)	9.6%
Earnings (TTM)	268.54 Cr
Earnings Growth (Yr)	6.3%

Profitability
Operating Margin	35%
EBT Margin	35%
Return on Equity	18.96%
Return on Assets	16.7%
Free Cashflow Yield	0.56%

Price to Sales Ratio

Latest reported: 12

Revenue (Last 12 mths)

Latest reported: 1 kCr

Net Income (Last 12 mths)

Latest reported: 269 Cr

Growth & Returns
Price Change 1W	-2.1%
Price Change 1M	-17.6%
Price Change 6M	-18.4%
Price Change 1Y	-24.7%
3Y Cumulative Return	-9.4%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-151.75 Cr
Cash Flow from Operations (TTM)	213.84 Cr
Cash Flow from Financing (TTM)	-52.51 Cr
Cash & Equivalents	20.03 Cr
Free Cash Flow (TTM)	71.89 Cr
Free Cash Flow/Share (TTM)	6.76

Balance Sheet
Total Assets	1.61 kCr
Total Liabilities	191.34 Cr
Shareholder Equity	1.42 kCr
Current Assets	799.03 Cr
Current Liabilities	155.56 Cr
Net PPE	711.26 Cr
Inventory	149.43 Cr
Goodwill	0.00

Capital Structure & Leverage
Debt Ratio	0.00
Debt/Equity	0.00
Interest Coverage	955.69
Interest/Cashflow Ops	565.22

Dividend & Shareholder Returns
Dividend/Share (TTM)	5
Dividend Yield	0.41%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Risk & Volatility
Max Drawdown	-39.5%
Drawdown Prob. (30d, 5Y)	48.24%
Risk Level (5Y)	39.1%

Pros

Balance Sheet: Strong Balance Sheet.

Technicals: Bullish SharesGuru indicator.

Profitability: Very strong Profitability. One year profit margin are 26%.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Size: Market Cap wise it is among the top 20% companies of india.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -17.6% in last 30 days.

Past Returns: Underperforming stock! In past three years, the stock has provided -9.4% return compared to 12% by NIFTY 50.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	0.41%
Dividend/Share (TTM)	5
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	25.27

Financial Health
Current Ratio	5.14
Debt/Equity	0.00

Technical Indicators
RSI (14d)	22.6
RSI (5d)	25.14
RSI (21d)	21.04
MACD Signal	Sell
Stochastic Oscillator Signal	Buy
Grufity Signal	Buy
RSI Signal	Buy
RSI5 Signal	Buy
RSI21 Signal	Buy
SMA 5 Signal	Sell
SMA 10 Signal	Sell
SMA 20 Signal	Sell
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Summary of Latest Earnings Report from Clean Science and Technology

Summary of Clean Science and Technology's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated:

In the Q1 FY25-26 earnings call, management provided an outlook that reflects a resilient business performance amidst global trade uncertainties. The standalone revenue decreased by 9% sequentially to INR 217 crores, while EBITDA and PAT stood at INR 101 crores and INR 77 crores respectively, achieving a record high EBITDA margin of over 46% since listing. Year-on-year sales remained steady, driven by a favorable product mix contributing to lower raw material costs (RMC), with established products contributing 83% to sales, up from 75% in Q4 and 80% in Q1 last year.

For the consolidated performance, total sales reached INR 240 crores, marking an 8% annual increase but a 6% sequential decline. Consolidated EBITDA was INR 100 crores with a 42% margin. The Heavy Anti-Lock Braking System (HALS) sales witnessed an upward trajectory, reporting an 8% sequential increase.

Management highlighted plans to commercialize advanced HALS grades priced between $11 to $35 per kg over the next two quarters, which they believe will positively impact margins. Capital expenditures of INR 80 crores were invested in the subsidiary Clean Fino-Chem Limited. Construction of Performance Chemical 1 is on track for a Q2 launch, and Performance Chemical 2 is expected to commercialize by Q4 FY26.

Looking ahead, management expressed an optimistic growth driver potential attributed to new product launches, estimating an addressable market expansion of over $1.7 billion within three quarters. The EBITDA growth guidance has been moderated to 15%-18% for the full year, given the prevailing market softness. The team remains positive about the gradual revenue acceleration anticipated from Q3 and Q4, driven by product developments and increasing market penetration.

Q&A Session

Last updated:

Question 1: Could you please what is the capacity utilization across the categories like MEHQ, Guaiacol, Palmitate?

Answer: Our capacity utilization across segments is as follows: Performance and FMCG are around 75%, Pharma is approximately 68%, and HALS is about 22% for the last quarter.

Question 2: Are you seeing any offtake momentum towards INR210 crore target for FY '26 for HALS 944 and 783?

Answer: Yes, the volume performance for HALS 944 and 783 this quarter has been encouraging, and we observed a positive contribution from these two projects in our sales mix.

Question 3: How much amount was deployed in the quarter 1 for capex guidance?

Answer: We infused INR 80 crores in quarter 1. Additionally, we anticipate another INR 120 crores to be invested in the subsidiary company.

Question 4: What explains the sharp swing in the gross profit margin in standalone versus consolidated numbers?

Answer: The fluctuation is primarily due to last quarter's higher closing stock, resulting in lower RMC. This quarter, our RMC for the subsidiary was around 62% due to this accounting impact.

Question 5: Is the 18%-20% EBITDA growth guidance still achievable given current business conditions?

Answer: We believe it could be moderated to range between 15% and 18%. Factors like DHDT's ramp-up and new HALS contributions will give us more clarity by Q2 end.

Question 6: Will the premium HALS products target similar customers or require us to scout for new customers?

Answer: We will target a similar customer base. Offering higher-grade HALS will help us align with European competitors and increase customer confidence in our product range.

Question 7: What timeline can we expect for sampling and ramping up production for new products?

Answer: The timeline for sample approvals and ramping up can vary, typically ranging from 2 to 6 months depending on the market.

Question 8: Can you elaborate on the intent to reduce the promoter stake?

Answer: The Boob family intends to sell a fraction of their equity, reducing total promoter holding from 75% to approximately 51%. This is driven by estate planning purposes.

Question 9: Is there any early sign of competition for MEHQ/anisole derivatives?

Answer: Not at the moment. We have been able to maintain our established products' volumes and have not lost any market share to competitors.

Question 10: What are expectations regarding the HALS target volume for FY '26?

Answer: We aim to maintain our volume target of 4,500 tons for FY '26. The introduction of newer HALS grades is expected to support achieving this target.

Share Holdings

Understand Clean Science and Technology ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
Ashok Ramnarayan Boob	12.8%
Ashokkumar Ramkishan Sikchi Huf	9.96%
Asha Ashok Boob	8.07%
Nidhi Mohunta	5.56%
Parth Ashok Maheshwari	5.56%
Ashok Ramnarayan Boob Huf	5.51%
Anantroop Financial Advisory Services Private Limited	3.92%
Pooja Vivek Navandar	3.22%
Prasad Krishnakumar Boob	3.22%
Shradha Krishnakumar Boob	3.22%
Krishnakumar Ramnarayan Boob Huf	3.04%
Siddhartha Ashok Sikchi	2.96%
Krishnakumar Ramnarayan Boob	2.65%
Nilima Krishnakumar Boob	2.32%
Kunal Ashok Sikchi	2.27%
Ashok Sikchi	2.07%
Nandita Sikchi	2%
Nomura India Investment Fund Mother Fund	1.53%
Asha Ashok Sikchi	0.52%
Santosh Lahoti	0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Clean Science and Technology Better than it's peers?

Detailed comparison of Clean Science and Technology against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
PIDILITIND	Pidilite Industries	1.45 LCr	13.39 kCr	-0.50%	-3.20%	66.66	10.56	-	-
NAVINFLUOR	Navin Fluorine International	25.26 kCr	2.6 kCr	-2.10%	+37.00%	69	9.72	-	-
ATUL	Atul	19.48 kCr	5.86 kCr	-13.20%	-17.70%	38.98	3.32	-	-
VINATIORGA	Vinati Organics	17.78 kCr	2.29 kCr	-15.10%	-24.80%	43.88	7.76	-	-
AARTIIND	Aarti Industries	14.73 kCr	7.1 kCr	-17.70%	-49.70%	104.19	2.07	-	-

Sector Comparison: CLEAN vs Chemicals & Petrochemicals

Comprehensive comparison against sector averages

Comparative Metrics

CLEAN metrics compared to Chemicals

Category	CLEAN	Chemicals
PE	47.33	49.80
PS	12.37	4.43
Growth	18.8 %	8.3 %

Performance Comparison

CLEAN vs Chemicals (2022 - 2025)

Key Insights

1. CLEAN is NOT among the Top 10 largest companies in Specialty Chemicals.
2. The company holds a market share of 0.7% in Specialty Chemicals.
3. In last one year, the company has had an above average growth that other Specialty Chemicals companies.

Income Statement for Clean Science and Technology

Consolidated figures (in Rs. Crores) / View Standalone Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Revenue From Operations	22.3%	967	791	936	685
Other Income	-5%	39	41	30	30
Total Income	20.7%	1,005	833	966	715
Cost of Materials	30.1%	368	283	338	245
Employee Expense	14.6%	56	49	45	35
Finance costs	-728.6%	0.42	0.93	0.2	0.15
Depreciation and Amortization	51.1%	69	46	36	25
Other expenses	28.6%	172	134	163	126
Total Expenses	28.1%	648	506	570	410
Profit Before exceptional items and Tax	9.5%	357	326	396	305
Total profit before tax	9.5%	357	326	396	305
Current tax	28%	97	76	98	73
Deferred tax	-197.6%	-4.39	6.52	2.5	3.36
Total tax	12.3%	92	82	100	76
Total profit (loss) for period	8.2%	264	244	295	228
Other comp. income net of taxes	13.1%	0.07	-0.07	0.13	-0.2
Total Comprehensive Income	8.2%	264	244	295	228
Earnings Per Share, Basic	8.7%	24.88	22.97	27.786	21.51
Earnings Per Share, Diluted	8.7%	24.88	22.96	27.778	21.51

Description	(%) Q/Q	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024
Revenue From Operations	-8%	243	264	241	238	224	228
Other Income	9.1%	13	12	5.22	11	9.93	14
Total Income	-7.3%	256	276	246	249	234	242
Cost of Materials	-4.2%	93	97	90	93	88	80
Employee Expense	0%	15	15	14	14	13	13
Finance costs	-8.1%	0.07	0.14	0.13	0.04	0.11	0.57
Depreciation and Amortization	12.5%	19	17	18	18	16	13
Other expenses	-8.5%	44	48	40	45	39	42
Total Expenses	-8%	162	176	161	166	145	146
Profit Before exceptional items and Tax	-5.1%	95	100	85	83	89	95
Total profit before tax	-5.1%	95	100	85	83	89	95
Current tax	0%	25	25	26	22	24	22
Deferred tax	-100%	-0.44	0.28	-5.98	2.05	-0.74	2.54
Total tax	-4.2%	24	25	20	24	23	25
Total profit (loss) for period	-5.5%	70	74	66	59	66	70
Other comp. income net of taxes	-14%	0.02	0.14	-0.02	-0.02	-0.02	-0.18
Total Comprehensive Income	-5.5%	70	74	66	59	66	70
Earnings Per Share, Basic	-6.4%	6.59	6.97	6.18	5.53	6.21	6.61
Earnings Per Share, Diluted	-6.4%	6.59	6.97	6.18	5.53	6.2	6.61

Standalone figures (in Rs. Crores) / View Consolidated Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Revenue From Operations	16.9%	922	789	936	685
Other Income	-5.4%	36	38	39	30
Total Income	15.7%	958	828	975	715
Cost of Materials	15.9%	322	278	338	245
Employee Expense	6.5%	50	47	45	35
Finance costs	-323.5%	0.28	0.83	0.15	0.15
Depreciation and Amortization	0%	44	44	36	25
Other expenses	14%	148	130	162	126
Total Expenses	14.3%	568	497	569	410
Profit Before exceptional items and Tax	18.2%	391	331	405	305
Total profit before tax	18.2%	391	331	405	305
Current tax	28%	97	76	98	73
Deferred tax	-91.4%	1.53	7.16	4.16	3.35
Total tax	18.3%	98	83	102	76
Total profit (loss) for period	17.8%	292	248	304	229
Other comp. income net of taxes	6.6%	0.01	-0.06	0.13	-0.2
Total Comprehensive Income	17.8%	292	248	304	228
Earnings Per Share, Basic	18.8%	27.51	23.31	28.57	21.522
Earnings Per Share, Diluted	18.8%	27.5	23.31	28.56	21.516

Description	(%) Q/Q	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024
Revenue From Operations	-10.2%	220	245	232	228	217	225
Other Income	9.1%	13	12	4.6	10	9.64	13
Total Income	-9.4%	233	257	236	238	227	239
Cost of Materials	-7.9%	71	77	81	83	80	75
Employee Expense	0%	13	13	12	12	12	12
Finance costs	-2.2%	0.05	0.07	0.1	0.02	0.09	0.54
Depreciation and Amortization	0%	11	11	11	11	11	11
Other expenses	-7.9%	36	39	35	39	35	39
Total Expenses	-14.6%	130	152	141	145	131	138
Profit Before exceptional items and Tax	-2.9%	102	105	96	94	96	101
Total profit before tax	-2.9%	102	105	96	94	96	101
Current tax	0%	25	25	26	22	24	23
Deferred tax	-134.6%	0.91	1.26	-4.2	3.9	0.56	3.23
Total tax	0%	26	26	21	26	24	26
Total profit (loss) for period	-2.6%	77	79	74	67	72	75
Other comp. income net of taxes	-6.4%	0	0.06	-0.02	-0.02	-0.02	-0.16
Total Comprehensive Income	-2.6%	77	79	74	67	72	75
Earnings Per Share, Basic	-3%	7.21	7.4	6.97	6.35	6.79	7.04
Earnings Per Share, Diluted	-3.1%	7.2	7.4	6.97	6.34	6.79	7.04

Balance Sheet for Clean Science and Technology

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022
Cash and cash equivalents	90%	20	11	10	5.28	12	49
Current investments	6.5%	344	323	302	290	328	276
Total current financial assets	8.2%	568	525	478	430	488	490
Inventories	0.7%	149	148	124	106	109	100
Current tax assets	-22.1%	0.06	0.23	0.22	0	0	0
Total current assets	8.9%	799	734	660	573	630	610
Property, plant and equipment	3.6%	711	686	599	451	422	327
Capital work-in-progress	0%	30	30	57	139	20	45
Investment property	-	0	0	37	0	37	0
Non-current investments	2.9%	37	36	37	53	26	0
Total non-current financial assets	0%	40	40	41	56	28	2.36
Total non-current assets	5.5%	809	767	737	657	521	412
Total assets	7.1%	1,608	1,501	1,396	1,231	1,152	1,022
Borrowings, non-current	-	0	0	0	0	0	0.72
Total non-current financial liabilities	-28.9%	1.96	2.35	2.33	2.34	2.32	0.72
Provisions, non-current	-2400%	0	0.96	0.83	0.58	0.58	0.13
Total non-current liabilities	-10.3%	36	40	33	29	26	18
Borrowings, current	-	0	0	0	1.1	0.05	0.07
Total current financial liabilities	3.6%	143	138	151	101	101	115
Provisions, current	154.1%	1.4	0.26	0.32	0.44	0.24	0.62
Current tax liabilities	-52.4%	7.67	15	6.59	6.55	5.91	15
Total current liabilities	-4.3%	156	163	160	111	116	138
Total liabilities	-6.4%	191	204	193	140	142	156
Equity share capital	0%	11	11	11	11	11	11
Total equity	9.2%	1,416	1,297	1,203	1,091	1,010	866
Total equity and liabilities	7.1%	1,608	1,501	1,396	1,231	1,152	1,022

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022
Cash and cash equivalents	55.6%	15	10	9.03	5.2	12	26
Current investments	19.5%	319	267	293	214	282	210
Total current financial assets	13.4%	518	457	465	354	444	402
Inventories	-14%	105	122	110	106	109	100
Total current assets	9.3%	645	590	591	470	577	522
Property, plant and equipment	-4.7%	364	382	397	417	422	327
Capital work-in-progress	53.9%	3.54	2.65	1.76	2.2	4.1	42
Investment property	-	0	0	3.8	0	3.88	0
Non-current investments	12.6%	589	523	373	329	147	121
Total non-current financial assets	12.6%	592	526	377	332	149	124
Total non-current assets	5.3%	959	911	780	753	582	508
Total assets	6.9%	1,605	1,501	1,371	1,223	1,159	1,030
Borrowings, non-current	-	0	0	0	0	0	0.72
Total non-current financial liabilities	-104.9%	0.98	1.41	1.4	1.4	1.39	0.72
Provisions, non-current	-566.7%	0	0.85	0.62	0.58	0.58	0.13
Total non-current liabilities	-10.5%	35	39	34	30	27	19
Borrowings, current	-	0	0	0	0	0	0.07
Total current financial liabilities	-9%	102	112	112	84	99	114
Provisions, current	111.2%	1.09	0.2	0.27	0.44	0.24	0.62
Current tax liabilities	-52.3%	7.68	15	6.59	6.77	5.89	14
Total current liabilities	-17.6%	113	137	121	95	113	137
Total liabilities	-16%	148	176	155	125	140	156
Equity share capital	0%	11	11	11	11	11	11
Total equity	10%	1,457	1,325	1,216	1,099	1,019	874
Total equity and liabilities	6.9%	1,605	1,501	1,371	1,223	1,159	1,030

Cash Flow for Clean Science and Technology

Consolidated figures (in Rs. Crores) / View Standalone Data

Finance costs	-728.6%
Change in inventories	-68.9%
Depreciation	51.1%
Unrealised forex losses/gains	56%
Dividend income	30.3%
Adjustments for interest income	60.6%
Share-based payments	-
Net Cashflows from Operations	-1.3%
Dividends received	-
Income taxes paid (refund)	27%
Net Cashflows From Operating Activities	-9.7%
Proceeds from sales of PPE	-119.9%
Purchase of property, plant and equipment	-39%
Proceeds from sales of long-term assets	-100.1%
Purchase of other long-term assets	-100.1%
Dividends received	30.3%
Interest received	-64%
Net Cashflows From Investing Activities	18.3%
Proceeds from exercise of stock options	57.1%
Payments of lease liabilities	-20.5%
Dividends paid	0%
Interest paid	-183.3%
Net Cashflows from Financing Activities	1.3%
Effect of exchange rate on cash eq.	-
Net change in cash and cash eq.	389.2%

Standalone figures (in Rs. Crores) / View Consolidated Data

Finance costs	-323.5%
Change in inventories	257.1%
Depreciation	0%
Unrealised forex losses/gains	44.9%
Dividend income	30.3%
Adjustments for interest income	60.4%
Share-based payments	-200%
Net Cashflows from Operations	6.2%
Dividends received	-
Income taxes paid (refund)	28.4%
Net Cashflows From Operating Activities	0.7%
Cashflows used in obtaining control of subsidiaries	0%
Proceeds from sales of PPE	-119.9%
Purchase of property, plant and equipment	-54.1%
Proceeds from sales of long-term assets	-100.2%
Purchase of other long-term assets	-100.2%
Dividends received	30.3%
Interest received	-65.4%
Net Cashflows From Investing Activities	2.8%
Proceeds from exercise of stock options	57.1%
Payments of lease liabilities	-7.5%
Dividends paid	0%
Interest paid	-208%
Net Cashflows from Financing Activities	1.2%
Effect of exchange rate on cash eq.	-
Net change in cash and cash eq.	210.6%

What does Clean Science and Technology Limited do?

Specialty Chemicals•Chemicals•Small Cap

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Industry Group:Chemicals & Petrochemicals

Employees:457

Website:www.cleanscience.co.in

CLEAN - Clean Science and Technology Limited Share Price

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Risk & Volatility

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Clean Science and Technology Limited do?